Skip to main content
Top
Published in: Journal of Nuclear Cardiology 1/2016

01-02-2016 | Brief Report

Upregulated myocardial CXCR4-expression after myocardial infarction assessed by simultaneous GA-68 pentixafor PET/MRI

Authors: C. Rischpler, MD, S. G. Nekolla, PhD, H. Kossmann, MD, R. J. Dirschinger, MD, M. Schottelius, PhD, F. Hyafil, MD, H. J. Wester, PhD, K. L. Laugwitz, MD, M. Schwaiger, MD

Published in: Journal of Nuclear Cardiology | Issue 1/2016

Login to get access

Excerpt

Just recently, inflammatory processes after myocardial infarction (MI) as an important additional factor for cardiac remodeling have come to the fore. As a consequence, there is an urgent unmet clinical need for tracers targeting specifically non-pathogen-driven, inflammatory processes in the heart. Here, we present the potential of a novel PET tracer targeting the expression of the chemokine receptor 4 (CXCR4) on inflammatory cells after acute MI. CXCR4 belongs to the family of G-protein-coupled receptors and is involved in biological processes such as the entry of HIV-1, the development of metastasis and several inflammatory conditions. The CXCR4 receptor is expressed only at low levels on the surface of circulating lymphocytes, macrophages, and neutrophils, but is highly upregulated when these cells infiltrate inflamed tissues. In addition, CXCR4 expression is strongly increased on the cell surface under hypoxic conditions via the stimulation of HIF (hypoxia-inducible factor). Therefore, the CXCR4 receptor represents an attractive molecular target to identify the presence of activated inflammatory cells located in the post-ischemic myocardium. …
Literature
1.
2.
go back to reference Demmer O, Gourni E, Schumacher U, Kessler H, Wester HJ. PET imaging of CXCR4 receptors in cancer by a new optimized ligand. Chem Med Chem 2011;6:1789–91.PubMedCentralCrossRefPubMed Demmer O, Gourni E, Schumacher U, Kessler H, Wester HJ. PET imaging of CXCR4 receptors in cancer by a new optimized ligand. Chem Med Chem 2011;6:1789–91.PubMedCentralCrossRefPubMed
3.
go back to reference Gourni E, Demmer O, Schottelius M, D’Alessandria C, Schulz S, Dijkgraaf I et al. PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent. J Nucl Med 2011;52:1803–10.CrossRefPubMed Gourni E, Demmer O, Schottelius M, D’Alessandria C, Schulz S, Dijkgraaf I et al. PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent. J Nucl Med 2011;52:1803–10.CrossRefPubMed
4.
go back to reference Wester HJ, Keller U, Schottelius M, Beer A, Philipp-Abbrederis K, Hoffmann F et al. Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging. Theranostics 2015;5:618–30.PubMedCentralCrossRefPubMed Wester HJ, Keller U, Schottelius M, Beer A, Philipp-Abbrederis K, Hoffmann F et al. Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging. Theranostics 2015;5:618–30.PubMedCentralCrossRefPubMed
5.
go back to reference Herrmann K, Lapa C, Wester HJ, Schottelius M, Schiepers C, Eberlein U, et al. Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68 Ga-pentixafor. J Nucl Med 2015;56:410–6.CrossRefPubMed Herrmann K, Lapa C, Wester HJ, Schottelius M, Schiepers C, Eberlein U, et al. Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68 Ga-pentixafor. J Nucl Med 2015;56:410–6.CrossRefPubMed
6.
go back to reference Philipp-Abbrederis K, Herrmann K, Knop S, Schottelius M, Eiber M, Lückerath K et al. In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma. EMBO Mol Med 2015;7:477–87.PubMedCentralCrossRefPubMed Philipp-Abbrederis K, Herrmann K, Knop S, Schottelius M, Eiber M, Lückerath K et al. In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma. EMBO Mol Med 2015;7:477–87.PubMedCentralCrossRefPubMed
Metadata
Title
Upregulated myocardial CXCR4-expression after myocardial infarction assessed by simultaneous GA-68 pentixafor PET/MRI
Authors
C. Rischpler, MD
S. G. Nekolla, PhD
H. Kossmann, MD
R. J. Dirschinger, MD
M. Schottelius, PhD
F. Hyafil, MD
H. J. Wester, PhD
K. L. Laugwitz, MD
M. Schwaiger, MD
Publication date
01-02-2016
Publisher
Springer US
Published in
Journal of Nuclear Cardiology / Issue 1/2016
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-015-0347-5

Other articles of this Issue 1/2016

Journal of Nuclear Cardiology 1/2016 Go to the issue

Nuclear Cardiology in the Literature

Review of cardiovascular literature

Journal of Nuclear Cardiology News Update

Leading ASNC in 2016: Putting the Strategic Plan into Action